Prostaglandin E2 inhibits the potassium current in sensory neurons from hyperalgesic Kv1.1 knockout mice

Neuroscience

Volumn 119, Issue 1, 2003, Pages 65-72

  Jiang, X ^a   Zhang, Y H ^a   Clark, J D ^b   Tempel, B L ^c   Nicol, G D ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Capsaicin; Potassium channel; Sensitization; Thermal and mechanical stimulation

Indexed keywords

POTASSIUM CHANNEL; POTASSIUM ION; PROSTAGLANDIN E2; KCNA1 PROTEIN, MOUSE; OXYTOCIC AGENT; POTASSIUM CHANNEL KV1.1; VOLTAGE GATED POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; GENE; HEAT SENSITIVITY; HYPERALGESIA; KNOCKOUT MOUSE; MECHANICAL STIMULATION; MOUSE; MOUSE STRAIN; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL; SENSORY NERVE CELL; SPECIES DIFFERENCE; STEADY STATE; WILD TYPE; ANIMAL; C3H MOUSE; CELL CULTURE; CELL MEMBRANE POTENTIAL; COMPARATIVE STUDY; ELECTRIC CONDUCTIVITY; GENETICS; GENOTYPE; HEART FUNCTION TEST; METABOLISM; MOUSE MUTANT; PERCEPTIVE THRESHOLD; PHYSIOLOGY; REACTION TIME; STIMULATION; TIME;

ANIMALS; BEHAVIOR, ANIMAL; CELLS, CULTURED; DINOPROSTONE; ELECTRIC CONDUCTIVITY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; GENOTYPE; HYPERALGESIA; KV1.1 POTASSIUM CHANNEL; MEMBRANE POTENTIALS; MICE; MICE, INBRED C3H; MICE, KNOCKOUT; NEURONS, AFFERENT; OXYTOCICS; PHYSICAL STIMULATION; POTASSIUM CHANNELS; POTASSIUM CHANNELS, VOLTAGE-GATED; REACTION TIME; SENSORY THRESHOLDS; TIME FACTORS;

EID: 0038664185     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00073-3     Document Type: Article

References (25)

1. Baccaglini P.I., Hogan P.G. Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells. Proc Natl Acad Sci USA. 80:1983;594-598.
2. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods. 53:1994;55-63.
3. Christie M.J. Molecular and functional diversity of K+ channels. Clin Exp Pharmacol Physiol. 22:1995;944-951.
4. Clark J.D., Tempel B.L. Hyperalgesia in mice lacking the Kv1.1 potassium channel gene. Neurosci Lett. 251:1998;121-124.
5. England S., Bevan S., Docherty R. PGE2 modulate the tetrodotoxin resistant sodium current in neonatal rat dorsal root ganglion via the cyclic AMP protein kinase A cascade. J Physiol. 495:1996;429-440.
6. Evans A.R., Vasko M.R., Nicol G.D. The cAMP transduction cascade mediates the PGE2- induced inhibition of potassium currents in rat sensory neurones. J Physiol. 516:1999;163-178.
7. Ferreira S.H., Nakamura M., Salete de Abreu M. The hyperalgesic effect of prostacyclin and prostaglandin E2. Prostaglandins. 16:1978;31-37.
8. Galeotti N., Ghelardini C., Papucci L., Capaccioli S., Quattrone A., Bartolini A. An antisense oligonucleotide on the mouse Shaker-like potassium channel Kv1.1 gene prevents antinociception induced by morphine and baclofen. J Pharmacol Exp Ther. 281:1997;1-9.
9. Gold M.S., Reichling D.B., Shuster M.J., Levine J.D. Hyperalgesic agents increase a tetrodotoxin-resistant Na+ current in nociceptors. Proc Natl Acad Sci USA. 93:1996;1108-1112.
10. Gold M.S., Levine J.D., Correa A.M. Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci. 18:1998;10345-10355.
11. Hamill O.P., Marty A., Neher E., Sakmann B., Sigworth F.J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 391:1981;85-100.
12. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1998;77-88.
13. Handwerker H.O., Kobal G. Psychophysiology of experimentally induced pain. Physiol Rev. 73:1993;639-671.
14. Hille B. Ionic channels of excitable membranes. 2001;Sinauer Associates, Sunderland, MA.
15. Holzer P. Capsaicin cellular targets, mechanisms of action, and selectivity for thin sensory neurons . Pharmacol Rev. 43:1991;143-201.
16. Hopkins W.F., Allen M.L., Houamed K.M., Tempel B.L. Properties of voltage-gated K+ currents expressed in Xenopus oocytes by mKv1.1, mKv1.2 and their heteromultimers as revealed by mutagenesis of the dendrotoxin-binding site in mKv1.1. Pflugers Arch. 428:1994;382-390.
17. Kress M., Reeh P.W. Chemical excitation and sensitization in nociceptors. Belmonte C., Cervero F. Neurobiology of nociceptors. 1996;258-297 Oxford University Press, Oxford.
18. Koren G., Liman E.R., Logothetis D.E., Nadal-Ginard B., Hess P. Gating mechanism of a cloned potassium channel expressed in frog oocytes and mammalian cells. Neuron. 4:1990;39-51.
19. Li X., Clark J.D. Morphine tolerance and transcription factor expression in mouse spinal cord tissue. Neurosci Lett. 272:1999;79-82.
20. Lindsay R.M. Nerve growth factors (NGF, BDNF) enhance axonal regeneration but are not required for survival of adult sensory neurons J. Neurosci. 8:1988;2394-2405.
21. Malmberg A.B., Brandon E.P., Idzerda R.L., Liu H., McKnight G.S., Basbaum A.I. Diminished inflammation and nociceptive pain with preservation of neuropathic pain in mice with a targeted mutation of the type I regulatory subunit of cAMP-dependent protein kinase. J Neurosci. 17:1997;7462-7470.
22. Nicol G.D., Cui M. Enhancement by prostaglandin E2 of bradykinin activation of embryonic rat sensory neurones. J Physiol. 480:1994;485-492.
23. Nicol G.D., Vasko M.R., Evans A.R. Prostaglandins suppress an outward potassium current in embryonic rat sensory neurons. J Neurophysiol. 77:1997;167-176.
24. Smart S.L., Lopantsev V., Zhang C.L., Robbins C.A., Wang H., Chiu S.Y., Schwartzkroin P.A., Messing A., Tempel B.L. Deletion of the K(V)1.1 potassium channel causes epilepsy in mice. Neuron. 20:1998;809-819.
25. Willis A.L., Cornelsen M. Repeated injection of prostaglandin E2 in rat paws induces chronic swelling and a marked decrease in pain threshold. Prostaglandins. 3:1973;353-357.